Replies to post #245697 on Biotech Values

[DewDiligence]

How could a pre-approval study possibly tease out such a rare risk…?

Those who voted no wanted PFE to run a pre-approval study with 200,000 subjects…………………………..

Just kidding! I honestly don’t know what the no voters wanted PFE to do about GBS. (I did not listen to the panel webcast.)

[Biowatch]

Pharma has poor track record on post-marketing studies and timely reporting of those results as far as I recall.